150 likes | 292 Views
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer. Switu Patel. Ovarian Cancer. Fifth in, malignant deaths of US women Cause unknown Common Therapy: surgery + chemotherapy. Dual treatments.
E N D
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel
Ovarian Cancer Fifth in, malignant deaths of US women Cause unknown Common Therapy: surgery + chemotherapy
Dual treatments • In Van et al. they combined Double stranded RNA (DsRNA) with therapeutic agents like paclitaxel and carboplatin to get a significant decrease in cell viability • DsRNA is known to stop the immunosuppression signals caused by ovarian tumor cells and activate four innate immune receptors
Cell response to dsRNA When stimulated within a cell, it activates four receptors.
Cell response to dsRNA DsRNA activates Protein Kinase and gives it a pro-apoptotic or cell killing response
Cell response to dsRNA Which then phosphorylates EIF2S which stops translation
Cell response to dsRNA PKR also activates FADD which further activates caspase 8 Apoptosis
Cell response to dsRNA Apoptosis Other pathways that influence apoptosis
Proposal question • What essential pathways related to apoptosis are activated by dsRNA + paclitaxel? • These pathways will serve as biomarkers for individual patients
Experiment • Apoptotic PCR Array • For: • Untreated • Treated: dsRNA, paclitaxel, dsRNA + paclitaxel
Hypothetical Results Caspase 3
Results • We expect that the samples treated with combined therapeutic agents will have a higher levels of apoptotic pathway molecules or lower CT values, than the individual treated samples. • However, it may cause down regulation of anti-apoptotic proteins or cause up regulation of pro-apoptotic or cell death proteins.